Effect of Chronic Exposure to Endocrine Disruptors on Female Fertility: A Toxicological Study

Female fertility is a finely regulated physiological process governed by a complex interplay of endocrine, paracrine, and autocrine signaling pathways, primarily orchestrated through the hypothalamic–pituitary–ovarian (HPO) axis. This axis involves the coordinated release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which stimulates the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. These hormones, in turn, regulate ovarian follicular development, ovulation, and steroid hormone production, including estrogen and progesterone. Any disruption in this tightly controlled hormonal network can lead to impaired reproductive function and reduced fertility.

In recent decades, increasing attention has been directed toward the impact of environmental factors on reproductive health, particularly the role of endocrine-disrupting chemicals (EDCs). EDCs are a diverse group of exogenous compounds that can interfere with normal endocrine function by mimicking natural hormones, blocking hormone receptors, or altering the synthesis, transport, metabolism, and elimination of endogenous hormones. These compounds are widely distributed in the environment and include industrial chemicals such as bisphenol A (BPA), phthalates, polychlorinated biphenyls (PCBs), dioxins, as well as pesticides, heavy metals, and certain pharmaceutical agents.

Human exposure to EDCs is nearly ubiquitous and occurs through multiple routes, including ingestion of contaminated food and water, inhalation of polluted air, and dermal contact with consumer products such as plastics, cosmetics, and personal care items. Due to their lipophilic nature and resistance to biodegradation, many EDCs persist in the environment and bioaccumulate in adipose tissues, leading to chronic, low-dose exposure over time. Importantly, exposure during critical windows of development—such as prenatal, neonatal, and pubertal periods—can have profound and long-lasting effects on reproductive health.

A growing body of epidemiological and experimental evidence suggests that chronic exposure to EDCs is associated with adverse effects on female reproductive outcomes. These effects include disruption of ovarian folliculogenesis, altered steroidogenesis, irregular menstrual cycles, reduced oocyte quality, and impaired endometrial receptivity. Mechanistically, EDCs have been shown to induce oxidative stress, mitochondrial dysfunction, epigenetic modifications, and apoptosis in ovarian cells. They may also interfere with key signaling pathways involved in follicle maturation and ovulation, ultimately compromising fertility.

Furthermore, EDC exposure has been implicated in the pathogenesis of several reproductive disorders, including polycystic ovary syndrome (PCOS), endometriosis, premature ovarian insufficiency (POI), and unexplained infertility. Despite these associations, the precise toxicological mechanisms underlying EDC-induced reproductive dysfunction remain incompletely understood. Challenges such as variability in exposure levels, mixture effects of multiple chemicals, and individual susceptibility complicate risk assessment and interpretation of findings.

Given the increasing prevalence of infertility and the widespread presence of EDCs in the environment, there is a pressing need for comprehensive research to elucidate their long-term effects on female reproductive health. This study aims to evaluate the reproductive toxicity associated with chronic exposure to endocrine-disrupting chemicals, with a particular focus on their impact on female fertility parameters, including ovarian function, hormonal balance, and implantation processes. Understanding these mechanisms will be essential for developing preventive strategies, regulatory policies, and therapeutic interventions to mitigate the adverse effects of EDCs on reproductive health.

2. OBJECTIVES

The present study is designed to comprehensively investigate the impact of chronic exposure to endocrine-disrupting chemicals (EDCs) on female reproductive health, with specific emphasis on hormonal regulation, ovarian structure, and fertility outcomes. The key objectives are as follows:

1. To assess the effect of chronic exposure to selected endocrine disruptors on female reproductive hormones

This objective aims to evaluate alterations in circulating levels of key reproductive hormones, including estrogen, progesterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH). The study will determine whether prolonged exposure to EDCs disrupts hormonal homeostasis and interferes with the normal functioning of the hypothalamic–pituitary–ovarian (HPO) axis.

2. To evaluate changes in ovarian morphology and follicular development

This includes histopathological examination of ovarian tissue to identify structural abnormalities such as follicular atresia, cyst formation, reduced corpus luteum formation, and impaired folliculogenesis. The objective also focuses on assessing different stages of follicle development (primordial, primary, secondary, and antral follicles) to understand the extent of ovarian damage.

3. To analyze estrous cycle irregularities and fertility outcomes

This objective involves monitoring the estrous cycle phases (proestrus, estrus, metestrus, and diestrus) to detect irregularities in cycle length and pattern. Additionally, fertility parameters such as mating success, conception rate, implantation rate, and litter size will be evaluated to determine the functional consequences of EDC exposure.

4. To elucidate possible toxicological mechanisms underlying EDC-induced reproductive dysfunction

This includes investigating molecular and cellular mechanisms such as oxidative stress, hormonal receptor modulation, mitochondrial dysfunction, apoptosis, and epigenetic alterations. The aim is to provide mechanistic insights into how EDCs impair reproductive processes at both cellular and systemic levels.

3. MATERIALS AND METHODS

3.1 Study Design

A controlled, experimental toxicological study was conducted to evaluate the effects of chronic exposure to selected endocrine-disrupting chemicals (EDCs) on female reproductive function. The study design was based on the principles outlined in the Organisation for Economic Co-operation and Development (OECD) guidelines for repeated-dose (90-day) oral toxicity studies. The experimental framework was structured to assess hormonal, histological, and functional fertility parameters following prolonged exposure to EDCs.

3.2 Chemicals

The endocrine disruptors selected for the study included:

• Bisphenol A (BPA)
• Di-(2-ethylhexyl) phthalate (DEHP)
• Chlorpyrifos

All chemicals were procured from certified suppliers and were of analytical grade purity (>99%). Stock solutions were prepared using appropriate vehicles and diluted to the required concentrations prior to administration. Care was taken to avoid contamination and ensure stability throughout the experimental period.

3.3 Experimental Animals

Healthy adult female Wistar rats (8–10 weeks old), weighing between 180–220 g, were used for the study. Animals were obtained from a registered animal facility and acclimatized for one week prior to experimentation.

The rats were housed in polypropylene cages under standard laboratory conditions, maintained at:

• Temperature: 22 ± 2°C
• Relative humidity: 50–60%
• Light/dark cycle: 12 h/12 h

Animals were provided with standard pellet diet and filtered water ad libitum. All experimental procedures were conducted in accordance with CPCSEA guidelines, and ethical approval was obtained from the Institutional Animal Ethics Committee (IAEC) prior to study initiation.

3.4 Exposure Protocol

Animals were randomly divided into four experimental groups (n = 6 per group):

• Group I (Control): Received vehicle only
• Group II (BPA-treated): Received Bisphenol A
• Group III (DEHP-treated): Received Di-(2-ethylhexyl) phthalate
• Group IV (Chlorpyrifos-treated): Received Chlorpyrifos

The selected EDCs were administered orally once daily for 90 consecutive days to simulate chronic environmental exposure. Doses were selected based on environmentally relevant exposure levels reported in previous toxicological studies.

Body weight, food intake, and general health status of the animals were monitored periodically throughout the study duration.

3.5 Evaluation of Fertility Parameters

3.5.1 Hormonal Assay

At the end of the treatment period, blood samples were collected via retro-orbital puncture under light anesthesia. Serum was separated by centrifugation and stored at −20°C until analysis.

Serum levels of reproductive hormones, including:

• Estrogen
• Progesterone
• Follicle-stimulating hormone (FSH)
• Luteinizing hormone (LH)

were quantified using commercially available enzyme-linked immunosorbent assay (ELISA) kits, following the manufacturer’s instructions.

3.5.2 Estrous Cycle Monitoring

The estrous cycle of each animal was monitored daily throughout the experimental period using vaginal smear cytology. Vaginal smears were collected using saline lavage and examined under a light microscope.

The phases of the estrous cycle—proestrus, estrus, metestrus, and diestrus—were identified based on the predominant cell types. Cycle length, frequency, and irregularities were recorded and analyzed.

3.5.3 Ovarian Histopathology

At the end of the study, animals were euthanized, and ovaries were excised, cleaned, and weighed. The tissues were fixed in 10% neutral buffered formalin for 24–48 hours.

Fixed tissues were processed, embedded in paraffin, sectioned at 4–5 µm thickness, and stained with hematoxylin and eosin (H&E). Histological examination was performed under a microscope to evaluate:

• Follicular development stages
• Presence of atretic follicles
• Corpus luteum formation
• Structural abnormalities (e.g., cysts, fibrosis)

3.5.4 Fertility Assessment

Following the treatment period, female rats from each group were cohabited with proven fertile male rats in a ratio of 2:1 (female:male).

Mating was confirmed by the presence of spermatozoa in vaginal smears. The following fertility parameters were assessed:

• Mating success rate (%)
• Number of implantation sites
• Pregnancy rate
• Litter size

Animals were observed throughout gestation to record reproductive outcomes.

3.6 Statistical Analysis

All experimental data were expressed as mean ± standard error of the mean (SEM). Statistical analysis was performed using one-way analysis of variance (ANOVA), followed by Tukey’s post hoc test for multiple comparisons.

A p-value < 0.05 was considered statistically significant. Data analysis was carried out using appropriate statistical software (e.g., GraphPad Prism/SPSS).

4. RESULTS (SIMULATED DATA)

4.1 Effect of EDCs on Reproductive Hormones

Chronic exposure to endocrine-disrupting chemicals resulted in significant alterations in serum reproductive hormone levels compared to the control group.

*p < 0.05 vs control

Interpretation:

• Significant decrease in estrogen and progesterone
• Significant increase in FSH and LH, indicating HPO axis disruption
• Chlorpyrifos showed the most pronounced effect

4.2 Estrous Cycle Analysis

EDC exposure led to marked disruption in estrous cyclicity.

Observations:

• Prolonged diestrus phase observed
• Irregular cycling increased significantly
• Chlorpyrifos group showed maximum disruption

4.3 Ovarian Histopathological Findings

Control Group

• Normal ovarian architecture
• Presence of healthy follicles at all stages
• Well-developed corpus luteum

BPA Group

• Mild follicular atresia
• Reduced number of antral follicles
• Occasional cystic follicles

DEHP Group

• Moderate follicular degeneration
• Increased atretic follicles
• Reduced corpus luteum formation

Chlorpyrifos Group

• Severe ovarian damage
• Extensive follicular atresia
• Multiple cystic structures
• Marked stromal fibrosis

4.4 Fertility Outcomes